VolitionRX Ltd (VNRX) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of various conditions including colorectal cancer, prostate and lung cancers, and inflammatory and other diseases. VolitionRX also conducts research and development, and offers clinical trial services. The company has collaboration with hospital, medical center, universities and research institute. It operates in Belgium, Singapore, the UK and the US. VolitionRX is headquartered in Singapore City, Singapore.

VolitionRX Ltd (VNRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
VolitionRX Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
VolitionRX Ltd, Medical Devices Deals, 2012 to YTD 2018 9
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
VolitionRx Acquires Nucleosomics Technology Patent from Chroma Therapeutics 11
Partnerships 12
VolitionRx Enters Into Licensing Agreement With Innova Biosciences For Biotin Technology 12
Singapore Volition to Enter into Agreement with National Taiwan University 13
VolitionRX Extends Research Agreement with University of Bonn 14
Equity Offering 15
VolitionRx to Raise USD6.6 Million in Private Placement of Shares 15
VolitionRX Raises USD8.4 Million in Public Offering of Shares 16
VolitionRx Raises USD14.1 Million in Public Offering of Shares 17
VolitionRx Completes Underwriters Exercise of Over-Allotment Option of Public Offering for USD10.6 Million 19
VolitionRx Completes Private Placement Of Shares For US$3 Million 21
Acquisition 22
ValiRx Divests Its Stake In VolitionRx For US$0.6 Million 22
VolitionRX Ltd - Key Competitors 23
VolitionRX Ltd - Key Employees 24
VolitionRX Ltd - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Aug 13, 2018: VolitionRx announces second quarter 2018 financial results and business update 26
May 10, 2018: VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update 28
Nov 09, 2017: VolitionRx Announces Third Quarter 2017 Financial Results and Business Update 29
Aug 09, 2017: VolitionRx Announces Second Quarter 2017 Financial Results and Business Update 31
May 11, 2017: VolitionRx Announces First Quarter 2017 Financial Results and Business Update 33
Mar 10, 2017: VolitionRx Announces Full Fiscal Year 2016 Financial Results and Business Update 34
Corporate Communications 36
Mar 07, 2018: VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board 36
Apr 11, 2017: VolitionRx Appoints David Vanston as Chief Financial Officer 37
Government and Public Interest 38
Sep 21, 2017: VolitionRx Limited Awarded $1.5 Million in Non-Dilutive Funding 38
Other Significant Developments 39
May 09, 2018: VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits 39
Mar 01, 2018: VolitionRX Announces Full Fiscal Year 2017 Financial Results and Business Update 40
Mar 28, 2017: Volition America Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List Of Tables


VolitionRX Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
VolitionRX Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
VolitionRX Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
VolitionRX Ltd, Medical Devices Deals, 2012 to YTD 2018 9
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
VolitionRx Acquires Nucleosomics Technology Patent from Chroma Therapeutics 11
VolitionRx Enters Into Licensing Agreement With Innova Biosciences For Biotin Technology 12
Singapore Volition to Enter into Agreement with National Taiwan University 13
VolitionRX Extends Research Agreement with University of Bonn 14
VolitionRx to Raise USD6.6 Million in Private Placement of Shares 15
VolitionRX Raises USD8.4 Million in Public Offering of Shares 16
VolitionRx Raises USD14.1 Million in Public Offering of Shares 17
VolitionRx Completes Underwriters Exercise of Over-Allotment Option of Public Offering for USD10.6 Million 19
VolitionRx Completes Private Placement Of Shares For US$3 Million 21
ValiRx Divests Its Stake In VolitionRx For US$0.6 Million 22
VolitionRX Ltd, Key Competitors 23
VolitionRX Ltd, Key Employees 24
VolitionRX Ltd, Subsidiaries 25

List Of Figures


VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
VolitionRX Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
VolitionRX Ltd, Medical Devices Deals, 2012 to YTD 2018 9

VolitionRX Ltd (VNRX) - Product Pipeline Analysis, 2018 Update

VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of

USD 750 View Report

VolitionRX Ltd (VNRX) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of

USD 250 View Report

VolitionRX Ltd (VNRX) - Product Pipeline Analysis, 2018 Update

VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of

USD 750 View Report

VolitionRX Ltd Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

VolitionRX Ltd Company Profile is a detailed strategic and analytical report on VolitionRX Ltd. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available